misonidazole has been researched along with Cancer of Cervix in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (72.41) | 18.7374 |
1990's | 2 (6.90) | 18.2507 |
2000's | 3 (10.34) | 29.6817 |
2010's | 3 (10.34) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguilera, TA; Giaccia, AJ | 1 |
Andrzejewski, P; Baltzer, P; Georg, D; Georg, P; Grimm, C; Helbich, TH; Karanikas, G; Mitterhauser, M; Pinker, K; Poetter, R; Polanec, SH; Polterauer, S; Sturdza, A; Wadsak, W | 1 |
Ali, S; Lanciano, R; Rose, PG; Stehman, FB; Whitney, CW | 1 |
Carson, J; Chan, P; Fyles, A; Milosevic, M; Pintilie, M; Rauth, M; Thomas, G | 1 |
Black, BE; Bush, RS; Cummings, BJ; Rauth, AM; Sorenti, VL; Thomas, GM | 1 |
Onoyama, Y | 1 |
Dar'ialova, SL; Kiseleva, ES | 1 |
Varghese, AJ; Whitmore, GF | 1 |
Omura, M | 1 |
Kishino, Y | 1 |
Asakawa, H; Hoshino, T; Watarai, J | 1 |
Kleine, W; Ladner, HA; Nagy, D; Stange, S | 1 |
Bleehen, NM | 1 |
Bennett, MH; Dische, S; Hauck, J; Minchinton, AI; Riley, PJ; Saunders, MI; Stratford, MR | 1 |
Bundy, BN; Creasman, WT; d'Ablaing, G; Fowler, WC; Keys, HM; Mortel, R; Stehman, FB; Thomas, G | 1 |
Asbell, SO; Cooper, J; Grigsby, PW; Keys, H; Marcial, V; Phillips, TL; Rotman, M; Wasserman, TH; Winter, K | 1 |
Anderson, LL; Donohue, KA; Heller, PB; Hernandez, E; Stehman, FB | 1 |
Banáth, JP; Durand, RE; Olive, PL | 1 |
Chapman, JD | 1 |
Denekamp, J; McNally, NJ | 1 |
Hammond, A; Sealy, R; Welsh, D | 1 |
Bentzen, SM; Bertelsen, K; Davy, M; Frankendal, B; Kjoerstad, K; Kolstad, P; Löftquist, I; Mäntyla, M; Overgaard, J; Skryten, A | 1 |
Bauer, M; Conner, N; Cooper, J; Gillespie, B; Hornback, N; Leibel, S; Marcial, V; Pakuris, E; Rotman, M; Wasserman, T | 2 |
Bundy, BN; Creasman, WT; Currie, JL; Keys, H; Mortel, R; Stehman, FB | 1 |
Adams, GE; Bleehen, NM; Dische, S; Freedman, LS; Henk, JM; Honess, DJ | 1 |
Bennett, MH; Des Rochers, C; Dische, S; Dunphy, EP; Minchinton, AI; Saunders, MI; Stratford, MR; Wardman, P | 1 |
Bonnay, M; Chassagne, D; Gerbaulet, A; Girinski, T; Haie, C; Malaise, E; Mazeron, JJ; Pejovic, MH | 1 |
2 review(s) available for misonidazole and Cancer of Cervix
Article | Year |
---|---|
[Electron acceptor compounds as radiation sensitizers of hypoxic cells in human tumors].
Topics: Brain Neoplasms; Combined Modality Therapy; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Metronidazole; Misonidazole; Mouth Neoplasms; Neoplasms; Radiation-Sensitizing Agents; Rectal Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 1984 |
Hypoxic sensitizers--implications for radiation therapy.
Topics: Animals; Female; Glioblastoma; Humans; Metronidazole; Misonidazole; Neoplasms; Oxygen Consumption; Radiation-Sensitizing Agents; Recurrence; Uterine Cervical Neoplasms | 1979 |
14 trial(s) available for misonidazole and Cancer of Cervix
Article | Year |
---|---|
A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Disease-Free Survival; Double-Blind Method; Female; Humans; Misonidazole; Radiation-Sensitizing Agents; Radiotherapy Dosage; Survival Rate; Uterine Cervical Neoplasms | 2004 |
A phase I study of misonidazole and pelvic irradiation in patients with carcinoma of cervix.
Topics: Double-Blind Method; Drug Evaluation; Female; Hearing Loss; Humans; Kinetics; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Random Allocation; Thrombocytopenia; Uterine Cervical Neoplasms | 1982 |
[Clinical trials of hypoxic cell sensitizer misonidazole].
Topics: Brain Neoplasms; Clinical Trials as Topic; Drug Evaluation; Female; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Misonidazole; Neoplasms; Nitroimidazoles; Oxygen; Random Allocation; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1983 |
The Medical Research Council trial of misonidazole in carcinoma of the uterine cervix. A report from the MRC Working Party on misonidazole for cancer of the cervix.
Topics: Adult; Aged; Brachytherapy; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Middle Aged; Misonidazole; Nitroimidazoles; Prognosis; Radiation Injuries; Radiotherapy Dosage; Uterine Cervical Neoplasms | 1984 |
Detection of a reactive metabolite of misonidazole in human urine.
Topics: Combined Modality Therapy; Female; Humans; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 1984 |
[Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
Topics: Aged; Esophageal Neoplasms; Female; Humans; Kidney; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Oxygen; Stomach Neoplasms; Tongue Neoplasms; Uterine Cervical Neoplasms | 1984 |
The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies.
Topics: Brain Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Glioma; Head and Neck Neoplasms; Humans; Kinetics; Misonidazole; Phenobarbital; Phenytoin; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 1980 |
Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Cause of Death; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Hydroxyurea; Life Tables; Middle Aged; Misonidazole; Recurrence; Survival Analysis; Uterine Cervical Neoplasms | 1993 |
Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Humans; Middle Aged; Misonidazole; Neoplasm Staging; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy Dosage; Treatment Failure; Uterine Cervical Neoplasms | 1999 |
The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Hydroxyurea; Incidence; Lymph Node Excision; Middle Aged; Misonidazole; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiation-Sensitizing Agents; Randomized Controlled Trials as Topic; Survival Analysis; Thrombocytosis; Uterine Cervical Neoplasms | 2000 |
Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Double-Blind Method; Female; Humans; Misonidazole; Multicenter Studies as Topic; Random Allocation; Uterine Cervical Neoplasms | 1989 |
Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial.
Topics: Adolescent; Adult; Aged; Brachytherapy; Carcinoma, Squamous Cell; Clinical Trials as Topic; Female; Humans; Middle Aged; Misonidazole; Radiotherapy; Radiotherapy, High-Energy; Random Allocation; Uterine Cervical Neoplasms | 1987 |
A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Hydroxyurea; Middle Aged; Misonidazole; Random Allocation; Uterine Cervical Neoplasms | 1988 |
Effect of misonidazole dose on survival in patients with stage IIIB-IVA squamous cell carcinoma of the uterine cervix: an RTOG randomized trial.
Topics: Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Misonidazole; Prognosis; Radiation-Sensitizing Agents; Random Allocation; Uterine Cervical Neoplasms | 1986 |
13 other study(ies) available for misonidazole and Cancer of Cervix
Article | Year |
---|---|
The end of the hypoxic EPOch.
Topics: Anemia; Blood Transfusion; Carcinoma, Squamous Cell; Cell Hypoxia; Clinical Trials as Topic; Erythropoietin; Etanidazole; Female; Head and Neck Neoplasms; Humans; Male; Misonidazole; Radiation-Sensitizing Agents; Receptors, Erythropoietin; Treatment Failure; Uterine Cervical Neoplasms | 2015 |
Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Hydroxyurea; Middle Aged; Misonidazole; Neoplasm Staging; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2011 |
[Experimental studies on radiosensitization of hypoxic cancer cells].
Topics: Animals; Carcinoma, Squamous Cell; Female; Humans; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Uterine Cervical Neoplasms | 1983 |
[Flow-microfluorometric studies on the effect of misonidazole as a radiosensitizer for human uterine cervical carcinoma transplanted to nude mice].
Topics: Animals; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Flow Cytometry; Humans; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Uterine Cervical Neoplasms | 1983 |
[Treatment with misonidazole and high voltage irradiation of xenotransplanted human carcinomas in nu/nu mice with thymic aplasia].
Topics: Animals; Cobalt Radioisotopes; Female; Genital Neoplasms, Female; Humans; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Ovarian Neoplasms; Radiotherapy, High-Energy; Uterine Cervical Neoplasms; Uterine Neoplasms | 1982 |
The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
Topics: Breast Neoplasms; Female; Humans; Misonidazole; Necrosis; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors; Uterine Cervical Neoplasms | 1981 |
The range of oxygenation in SiHa tumor xenografts.
Topics: Animals; Carcinoma; Cell Survival; Comet Assay; DNA Damage; Female; Humans; In Vitro Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Misonidazole; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2002 |
The magnitude of hypoxic cell cytotoxicity of misonidazole in human tumours.
Topics: Cell Survival; Female; Humans; In Vitro Techniques; Misonidazole; Nitroimidazoles; Oxygen; Uterine Cervical Neoplasms | 1978 |
Palliative topical and systemic misonidazole with low-dose irradiation for recurrent carcinoma of the cervix uteri.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Misonidazole; Neoplasm Recurrence, Local; Palliative Care; Radiotherapy Dosage; Uterine Cervical Neoplasms | 1986 |
Does initial haemoglobin level modify the efficacy of radiosensitizers? An analysis of the MRC misonidazole studies in head and neck cancer and cervix cancer.
Topics: Combined Modality Therapy; Female; Head and Neck Neoplasms; Hemoglobins; Humans; Male; Misonidazole; Prognosis; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 1987 |
A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799.
Topics: Adult; Aged; Animals; Carcinoma, Squamous Cell; Cricetinae; Cricetulus; Female; Humans; Male; Melanoma; Mice; Middle Aged; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 1986 |
Radical irradiation and misonidazole in the treatment of advanced cervical carcinoma: results of a phase II trial.
Topics: Female; Humans; Lymph Nodes; Misonidazole; Radiotherapy Dosage; Uterine Cervical Neoplasms | 1985 |